216 related articles for article (PubMed ID: 32334453)
1. The Potential of Atractylodin-Loaded PLGA Nanoparticles as Chemotherapeutic for Cholangiocarcinoma.
Muhamad N; Plengsuriyakarn T; Chittasupho C; Na-Bangchang K
Asian Pac J Cancer Prev; 2020 Apr; 21(4):935-941. PubMed ID: 32334453
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity.
Arvas B; Ucar B; Acar T; Varli HS; Arvas MB; Aydogan F; Yolacan C
Nanotechnology; 2024 May; 35(30):. PubMed ID: 38636487
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
4. Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension.
Kecel-Gündüz S; Budama-Kilinc Y; Cakir Koc R; Kökcü Y; Bicak B; Aslan B; Özel AE
J Biomol Struct Dyn; 2018 Aug; 36(11):2893-2907. PubMed ID: 28835169
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of a new quinoxaline derivative in PLGA alters the pattern of its anticancer potency and induces apoptosis.
Saad EA; Waly HM
Cancer Chemother Pharmacol; 2019 Apr; 83(4):649-658. PubMed ID: 30648201
[TBL] [Abstract][Full Text] [Related]
6. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
7. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy.
Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G
AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689
[TBL] [Abstract][Full Text] [Related]
8. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells.
Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA
Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic activity and molecular targets of atractylodin in cholangiocarcinoma cells.
Mathema VB; Chaijaroenkul W; Na-Bangchang K
J Pharm Pharmacol; 2019 Feb; 71(2):185-195. PubMed ID: 30324612
[TBL] [Abstract][Full Text] [Related]
10. Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway.
Vanaroj P; Chaijaroenkul W; Na-Bangchang K
Asian Pac J Cancer Prev; 2023 Feb; 24(2):551-558. PubMed ID: 36853304
[TBL] [Abstract][Full Text] [Related]
11. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
12. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A
Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665
[TBL] [Abstract][Full Text] [Related]
13. Levofloxacin loaded chitosan and poly-lactic-co-glycolic acid nano-particles against resistant bacteria: Synthesis, characterization and antibacterial activity.
Hayee R; Iqtedar M; Albekairi NA; Alshammari A; Makhdoom MA; Islam M; Ahmed N; Rasool MF; Li C; Saeed H
J Infect Public Health; 2024 May; 17(5):906-917. PubMed ID: 38569270
[TBL] [Abstract][Full Text] [Related]
14. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
Rafiei P; Haddadi A
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976
[TBL] [Abstract][Full Text] [Related]
15. Enhanced oral bioavailability and biodistribution of atractylodin encapsulated in PLGA nanoparticle in cholangiocarcinoma.
Omar AI; Plengsuriyakarn T; Chittasupho C; Na-Bangchang K
Clin Exp Pharmacol Physiol; 2021 Mar; 48(3):318-328. PubMed ID: 33125766
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
17. Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design.
Dhal C; Mishra R
Drug Dev Ind Pharm; 2019 May; 45(5):805-818. PubMed ID: 30698993
[TBL] [Abstract][Full Text] [Related]
18. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
19. The impact of camptothecin-encapsulated poly(lactic-
Bao H; Zhang Q; Yan Z
Int J Nanomedicine; 2019; 14():383-391. PubMed ID: 30662262
[TBL] [Abstract][Full Text] [Related]
20. Design of PLGA nanoparticles for sustained release of hydroxyl-FK866 by microfluidics.
Bai X; Tang S; Butterworth S; Tirella A
Biomater Adv; 2023 Nov; 154():213649. PubMed ID: 37820459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]